Best AI Science Software of 2026 - Page 2

LeapSpace is an advanced, AI-enhanced research platform created by Elsevier to accelerate the journey from inquiry to innovation for both academic and corporate researchers within a secure and reliable setting. This innovative workspace integrates responsible artificial intelligence with one of the largest repositories of peer-reviewed scientific literature, which includes millions of full-text articles and over 100 million abstracts from a diverse array of publishers, ensuring that insights are based on credible evidence rather than raw internet information. By leveraging natural-language queries, LeapSpace allows users to delve into intricate research themes, providing structured, cited responses that facilitate the review of primary sources and the validation of results. Furthermore, LeapSpace is designed to support the comprehensive research process, enabling users to brainstorm ideas, organize projects, analyze existing literature, compare various studies, and generate detailed reports that uncover trends, inconsistencies, and gaps in current research. This holistic approach not only enhances research efficiency but also empowers users to deepen their understanding of their fields.

Osmosis AI serves as an interactive study companion seamlessly integrated into the Osmosis learning platform, aimed at assisting medical and health professional students in grasping, reviewing, and solidifying intricate subjects through a mix of AI-driven explanations and reputable educational resources. It combines Elsevier's vast collection of peer-reviewed medical textbooks and materials with the Osmosis visual learning approach, providing responses that are evidence-based, properly cited, and linked to pertinent videos, diagrams, and study aids. This innovative tool allows students to inquire in real time without disrupting their study routine, offering straightforward explanations in accessible language along with direct citations to the original sources for validation. Unlike many platforms that depend on open web data, Osmosis AI functions within a defined "walled garden" of carefully selected medical content, minimizing the occurrence of inaccuracies and ensuring alignment with the educational standards for teaching and assessment in the medical field. As a result, students can engage in a more focused and reliable learning experience that enhances their understanding of complex topics.

ResoluteAI offers a secure platform that allows users to simultaneously search through a variety of aggregated scientific, regulatory, and business databases. The platform's interactive analytics and downloadable visualizations enable users to forge connections that may lead to significant breakthroughs. Nebula, which is ResoluteAI's enterprise search solution tailored for the scientific community, leverages structured metadata alongside a suite of AI tools that enhance your institutional knowledge. This sophisticated approach incorporates various technologies such as natural language processing, optical character recognition, image recognition, and transcription, making it easier to locate and access proprietary information. With Nebula, researchers have the capability to reveal the latent value within their studies, experiments, market intelligence, and acquired assets. By utilizing structured metadata derived from unstructured text, users benefit from features like semantic expansion, conceptual search, and document similarity search, ensuring a comprehensive exploration of their data. This innovative platform transforms the way scientific data is accessed and utilized, paving the way for enhanced research outcomes.

ScienceDesk's data automation simplifies the integration of artificial intelligence within the field of materials science. This tool serves as a practical solution for teams to consistently implement and utilize the latest AI algorithms in their daily workflows. It features customizable attributes, universal identifiers, QR codes, and a robust search engine that connects sample data with experimental results. As a groundbreaking platform, ScienceDesk facilitates collaboration among scientists and engineers, allowing them to engage with and glean insights from their experimental findings. However, the full potential of this resource remains untapped due to the diverse data formats and a reliance on specialists to manually retrieve targeted information. The ScienceDesk research data management system addresses this challenge by merging documentation with data analysis within a thoughtfully designed data structure. Our algorithms empower researchers and scientists, granting them comprehensive command over their data. They can not only exchange datasets but also share their analytical expertise, fostering a more collaborative research environment. Overall, ScienceDesk enhances data accessibility and encourages innovative approaches in scientific investigation.

Streamline the entire selection process for reagents and model systems to eliminate costly inefficiencies and errors that lead to experimental failures. Accelerate project timelines by facilitating the selection of reagents and model systems in a mere 30 seconds, compared to the traditional 12-week duration. This transformation can significantly cut the hard costs associated with consumables, saving organizations millions annually. By restoring valuable research time to scientists, you can enhance the organization’s mission. Experience tangible business benefits from AI through a proven, ready-to-use application. More than 41,200 scientists across 15 of the leading 20 pharmaceutical companies, as well as over 4,450 academic institutions, leverage BenchSci’s AI-Assisted Antibody Selection to design more effective experiments, resulting in documented savings of millions per year in hard costs alone. However, it's important to note that antibodies account for only 40-50% of reagent-related failures. Access a comprehensive array of experimental evidence, along with catalog data for reagents and model systems, all within one user-friendly interface. This platform integrates real-world experiment data sourced from 11.2 million scientific publications, including those published in closed-access journals, providing an unparalleled resource for researchers. With this level of detailed information, scientists can make informed decisions that significantly enhance their research outcomes.

At Iris.ai we have spent the last 6 years building an award-winning AI engine for scientific text understanding. Our algorithms for text similarity, tabular data extraction, domain-specific entity representation learning and entity disambiguation and linking measure up to the best in the world. On top of that, our machine builds a comprehensive knowledge graph containing all entities and their linkages to allow humans to learn from it, use it and also give feedback to the system. The Iris.ai Researcher Workspace is a flexible tool suite that allows to approach a project in a variety of ways. Modules include content based explorative search, machine analysis of document sets, extracting and systematizing data points, automatically writing summaries of multiple documents - and very powerful filters based on context descriptions, the machine’s analysis, or specific data points or entities. The Iris.ai engine for scientific text understanding is a powerful interdisciplinary system that can be automatically reinforced on a specific research field for much more nuanced machine understanding - without human training or annotation.

Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.

Proteins, which are remarkably complex machines, play a crucial role not only in the biological functions of your body but also in every living organism's processes. They serve as the fundamental units of life. As of now, there are approximately 100 million identified proteins, with discoveries being made regularly. Each protein possesses a distinctive three-dimensional shape that is essential to its functionality and purpose. However, determining a protein's precise structure is often a costly and lengthy endeavor, resulting in an understanding of only a small percentage of the proteins recognized by science. Addressing this growing disparity and developing methods to predict the structures of millions of yet-to-be-discovered proteins could significantly advance our ability to combat diseases, expedite the discovery of new treatments, and potentially unveil the secrets of life's mechanisms. The implications of such advancements could transform both medicine and our understanding of biology.

BioNeMo is a cloud service and framework for drug discovery that leverages AI, built on NVIDIA NeMo Megatron, which enables the training and deployment of large-scale biomolecular transformer models. This service features pre-trained large language models (LLMs) and offers comprehensive support for standard file formats related to proteins, DNA, RNA, and chemistry, including data loaders for SMILES molecular structures and FASTA sequences for amino acids and nucleotides. Additionally, users can download the BioNeMo framework for use on their own systems. Among the tools provided are ESM-1 and ProtT5, both transformer-based protein language models that facilitate the generation of learned embeddings for predicting protein structures and properties. Furthermore, the BioNeMo service will include OpenFold, an advanced deep learning model designed for predicting the 3D structures of novel protein sequences, enhancing its utility for researchers in the field. This comprehensive offering positions BioNeMo as a pivotal resource in modern drug discovery efforts.

Clara provides specialized tools and pre-trained AI models that are driving significant advancements across various sectors, such as healthcare technologies, medical imaging, pharmaceutical development, and genomic research. Delve into the comprehensive process of developing and implementing medical devices through the Holoscan platform. Create containerized AI applications using the Holoscan SDK in conjunction with MONAI, and enhance deployment efficiency in next-gen AI devices utilizing the NVIDIA IGX developer kits. Moreover, the NVIDIA Holoscan SDK is equipped with acceleration libraries tailored for healthcare, alongside pre-trained AI models and sample applications designed for computational medical devices. This combination of resources fosters innovation and efficiency, positioning developers to tackle complex challenges in the medical field.

NVIDIA® Parabricks® stands out as the sole suite of genomic analysis applications that harnesses GPU acceleration to provide rapid and precise genome and exome analysis for various stakeholders, including sequencing centers, clinical teams, genomics researchers, and developers of high-throughput sequencing instruments. This innovative platform offers GPU-optimized versions of commonly utilized tools by computational biologists and bioinformaticians, leading to notably improved runtimes, enhanced workflow scalability, and reduced computing expenses. Spanning from FastQ files to Variant Call Format (VCF), NVIDIA Parabricks significantly boosts performance across diverse hardware setups featuring NVIDIA A100 Tensor Core GPUs. Researchers in genomics can benefit from accelerated processing throughout their entire analysis workflows, which includes stages such as alignment, sorting, and variant calling. With the deployment of additional GPUs, users can observe nearly linear scaling in computational speed when compared to traditional CPU-only systems, achieving acceleration rates of up to 107X. This remarkable efficiency makes NVIDIA Parabricks an essential tool for anyone involved in genomic analysis.

Precision, efficiency, and assurance. The integration of generative AI into the biopharmaceutical industry is here. This technology streamlines the arduous task of gathering, organizing, and analyzing extensive data sets. Achieve essential insights with complete assurance every single time. With our AI-driven platform for data handling and validation, you will keep your workflows organized effortlessly. Collect, process, and verify your data all from a single interface. Easily search through both public and private databases using key characteristics of drugs. Categorize drugs and clinical trials based on comprehensive patient demographics. Retrieve necessary data in straightforward language. Strengthen your conclusions by linking your findings to their original sources. Direct your focus towards creating valuable outputs from your data, bypassing the tedious manual sorting process. Our advanced language models empower researchers to conduct asset evaluations 4.8 times quicker than traditional methods. We provide access to an extensive index of over 38 million scientific articles, conference papers, and clinical trial data. With this system, you’ll have all the information you require at your fingertips, ensuring timely and informed decision-making. Additionally, our platform adapts to your unique needs, enhancing the research experience even further.

Cure AI represents a cutting-edge medical research platform that harnesses the power of artificial intelligence to grant users access to an extensive library of over 26 million scientific publications sourced from PubMed. With its AI-driven natural language processing capabilities, users can pose research questions in a conversational manner, which the system accurately decodes to return specific and relevant results. It also boasts sophisticated search filters that allow users to narrow down findings by factors such as journal, date of publication, and various other criteria, catering to individual research requirements. Additionally, Cure AI evaluates evidence based on its quality and significance, taking into account metrics like the journal's h5-index, citation tally, and the type of publication, thereby ensuring users obtain the most relevant and credible information available. The platform further enhances user experience by allowing easy transitions between AI-generated insights and original literature, streamlining the process of literature review and analysis. Moreover, it comes equipped with convenient citation tools that enable users to quickly copy or share references with just one click, simplifying the documentation process. Finally, the intuitive design of Cure AI encourages researchers to explore new avenues of inquiry with confidence and ease.

Biologit provides an extensive range of software and services aimed at improving safety surveillance in multiple sectors. Their leading offering, biologit MLM-AI, is a comprehensive medical literature monitoring system that utilizes AI technology for both global and local applications. This user-friendly, web-based platform is validated for compliance, resulting in enhanced efficiency for both human and veterinary pharmacovigilance. Notable features encompass integrated search capabilities and customizable literature screening processes, yielding productivity improvements of up to 70% thanks to AI support. Additionally, it presents a flexible and validated SaaS framework that meets GxP standards and adheres to CFR-11 regulations, alongside a database that consolidates significant global and local literature resources while ensuring automatic article de-duplication. Beyond their software offerings, Biologit also provides expert consultancy services related to pharmacovigilance and veterinary pharmacovigilance, further strengthening their commitment to safety in various fields. Their dedication to innovation and compliance positions them as a leader in the industry.

PubHive Navigator is an innovative software solution that utilizes artificial intelligence to enhance the efficiency of scientific literature and safety processes for life science organizations, regardless of their size. It provides a comprehensive suite of workflow solutions that encompass literature review, curation, annotation, collaboration, searching, reporting, citation management, and research oversight. The platform boasts AI-driven smart workspaces that facilitate centralized management of literature, collaborative writing for research projects, and effective team communication, along with integrations for document delivery and reuse rights, as well as pre-configured workflows tailored to various operational units. Furthermore, PubHive Navigator aims to streamline the complexities associated with enterprise-level scientific literature and safety information workflows, thereby offering a versatile tool for teams engaged in drug safety and pharmacovigilance, medical affairs, clinical affairs, and research and development. This adaptability allows organizations to optimize their research processes and enhance productivity across their teams.

Evo 2 represents a cutting-edge genomic foundation model that excels in making predictions and designing tasks related to DNA, RNA, and proteins. It employs an advanced deep learning architecture that allows for the modeling of biological sequences with single-nucleotide accuracy, achieving impressive scaling of both compute and memory resources as the context length increases. With a robust training of 40 billion parameters and a context length of 1 megabase, Evo 2 has analyzed over 9 trillion nucleotides sourced from a variety of eukaryotic and prokaryotic genomes. This extensive dataset facilitates Evo 2's ability to conduct zero-shot function predictions across various biological types, including DNA, RNA, and proteins, while also being capable of generating innovative sequences that maintain a plausible genomic structure. The model's versatility has been showcased through its effectiveness in designing operational CRISPR systems and in the identification of mutations that could lead to diseases in human genes. Furthermore, Evo 2 is available to the public on Arc's GitHub repository, and it is also incorporated into the NVIDIA BioNeMo framework, enhancing its accessibility for researchers and developers alike. Its integration into existing platforms signifies a major step forward for genomic modeling and analysis.

FutureHouse is a nonprofit research organization dedicated to harnessing AI for the advancement of scientific discovery in biology and other intricate disciplines. This innovative lab boasts advanced AI agents that support researchers by speeding up various phases of the research process. Specifically, FutureHouse excels in extracting and summarizing data from scientific publications, demonstrating top-tier performance on assessments like the RAG-QA Arena's science benchmark. By utilizing an agentic methodology, it facilitates ongoing query refinement, re-ranking of language models, contextual summarization, and exploration of document citations to improve retrieval precision. In addition, FutureHouse provides a robust framework for training language agents on demanding scientific challenges, which empowers these agents to undertake tasks such as protein engineering, summarizing literature, and executing molecular cloning. To further validate its efficacy, the organization has developed the LAB-Bench benchmark, which measures language models against various biology research assignments, including information extraction and database retrieval, thus contributing to the broader scientific community. FutureHouse not only enhances research capabilities but also fosters collaboration among scientists and AI specialists to push the boundaries of knowledge.

Zochi stands out as the first autonomous AI system capable of completing the entire scientific research cycle, ranging from formulating hypotheses to achieving peer-reviewed publication, while generating cutting-edge outcomes. In contrast to previous systems that were confined to specific, well-defined tasks, Zochi thrives in confronting research challenges that are at the cutting edge of artificial intelligence. The system's effectiveness is demonstrated through a series of peer-reviewed papers accepted at the ICLR 2025 workshops, highlighting Zochi's capacity to produce innovative and academically sound contributions. Furthermore, Zochi recognized a significant obstacle within the AI field: the issue of cross-skill interference during parameter-efficient fine-tuning. This problem arises when models are adapted for multiple tasks at once, leading to enhancements in one skill that may negatively impact others. To combat this challenge, Zochi introduced a novel approach called CS-ReFT (Compositional Subspace Representation Fine-tuning), which emphasizes the editing of representations instead of altering weights. This groundbreaking method has the potential to revolutionize how AI systems are fine-tuned for diverse applications.

Sciscoper is an AI-driven research assistant designed to enhance and expedite the literature review process for professionals in STEM fields, including researchers, academics, and R&D teams. Given the challenge researchers face with managing extensive collections of scientific papers from various sources, extracting valuable insights can often become a cumbersome task. To address this issue, Sciscoper leverages AI and natural language processing capabilities to automatically: - Summarize scientific articles and research outcomes. - Identify crucial insights, concepts, and interconnections within documents. - Create literature reviews complete with citations in diverse referencing formats. - Organize and categorize papers into a well-structured, searchable knowledge repository for convenient access. As a result, users can minimize the time spent on tedious reading and note-taking, allowing them to concentrate more on analyzing findings, recognizing areas for further research, and contributing to the advancement of scientific knowledge. Ultimately, Sciscoper transforms the literature review process, making it more efficient and effective for its users.

Gemini 3, the latest model from Google DeepMind, establishes a new standard for artificial intelligence by achieving cutting-edge reasoning capabilities and multimodal comprehension across various formats including text, images, and videos. It significantly outperforms its earlier version in critical AI assessments and showcases its strengths in intricate areas like scientific reasoning, advanced programming, spatial reasoning, and visual or video interpretation. The introduction of the innovative “Deep Think” mode takes performance to an even higher level, demonstrating superior reasoning abilities for exceptionally difficult tasks and surpassing the Gemini 3 Pro in evaluations such as Humanity’s Last Exam and ARC-AGI. Now accessible within Google’s ecosystem, Gemini 3 empowers users to engage in learning, developmental projects, and strategic planning with unprecedented sophistication. With context windows extending up to one million tokens and improved media-processing capabilities, along with tailored configurations for various tools, the model enhances precision, depth, and adaptability for practical applications, paving the way for more effective workflows across diverse industries. This advancement signals a transformative shift in how AI can be leveraged for real-world challenges.

Prism is a free, cloud-based LaTeX workspace built specifically for scientific writing and collaboration. It combines drafting, compiling, and version control into one unified platform, eliminating the need for local environments or external tools. Prism integrates GPT-5.2 directly into the workflow, offering AI-powered proofreading, formatting assistance, and literature discovery. The platform supports unlimited collaborators with real-time editing and instant previews, removing version conflicts and manual merges. Project-aware AI understands the full manuscript context, helping refine structure, logic, equations, and references as drafts evolve. Built-in tools handle citation management, LaTeX rendering, and automated error detection. Prism allows researchers to focus more on ideas and less on formatting details. Features like voice-to-code, image-to-code, and AI-driven fixes further accelerate writing tasks. Unlimited projects and compile time make it suitable for both short papers and long-form research. Prism sets a new benchmark for collaborative scientific writing.

BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.

Gemini for Science enhances the process of scientific discovery by offering AI-driven tools and resources specifically designed to bolster scientific initiatives. By integrating experimental tools found in Google Labs with the science workflows offered through Google Antigravity, it aims to expedite research, improve analytical reasoning, and enable researchers to delve into the future of AI-enhanced scientific exploration. The Literature Insights feature compiles scholarly literature to uncover new research possibilities, produce well-founded research artifacts, and convert paper information into structured tables linked directly to original evidence. Meanwhile, Hypothesis Generation employs a multi-agent approach that emulates the scientific method, allowing it to pinpoint knowledge gaps, suggest viable research avenues, and outline testable research plans that could lead to significant breakthroughs. Additionally, Computational Discovery assists researchers in identifying models and algorithms through an intelligent research engine that creates and evaluates code variations according to user-specified optimization criteria, thereby streamlining the research process even further. Ultimately, these innovative tools collectively aim to revolutionize how scientific research is conducted and understood.

Biohub serves as an accessible platform dedicated to advancing the understanding of protein biology. It offers users the ESM model family, which includes ESMC, ESMFold2, and ESM3, alongside interactive tools and resources tailored for developers involved in protein science research. ESMC stands out as a cutting-edge protein language model, meticulously trained on vast amounts of evolutionary sequence data, allowing it to create representations that elucidate key mechanisms underlying protein structure and function. This model facilitates various applications such as functional analysis, predicting structures, designing proteins, and investigating the evolutionary connections among different proteins. Meanwhile, ESMFold2 specializes in predicting high-resolution, all-atom 3D structures of biomolecular complexes from sequences, while offering the option of including multiple sequence alignments to improve accuracy for difficult targets. Additionally, ESM3 takes a holistic approach by simultaneously modeling sequence, structure, and function, thus enabling the generation of innovative proteins through conditioning on a blend of these aspects. This unique integration of tools and models empowers researchers to explore new frontiers in protein science.

Everstar is an innovative AI-driven platform aimed at enhancing the deployment of nuclear power by leveraging document intelligence, offering licensing assistance, managing regulatory workflows, conducting engineering analysis, and automating nuclear compliance processes. Tailored for nuclear industry professionals, Everstar empowers teams to transform intricate documents into actionable insights, enabling them to create filings that meet regulatory standards, quickly identify relevant precedents, shorten siting timelines, and optimize operations across the entire nuclear value chain while maintaining safety as a top priority. With its advanced AI capabilities, Everstar addresses some of the most challenging administrative, regulatory, and engineering obstacles in the field, ensuring accuracy, traceability, and secure operational workflows. The platform is versatile enough to cater to various stakeholders, including those involved in operating reactor licensing, reactor management and engineering, new reactor approvals, radioactive materials handling, as well as manufacturing and supply chain departments, along with regulatory bodies. This comprehensive support fosters collaboration among different sectors of the nuclear industry, ultimately leading to more efficient processes and safer outcomes.